[go: up one dir, main page]

DK170802B1 - Azabicycliske ethere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og far maceutiske præparater indeholdende dem - Google Patents

Azabicycliske ethere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og far maceutiske præparater indeholdende dem Download PDF

Info

Publication number
DK170802B1
DK170802B1 DK434488A DK434488A DK170802B1 DK 170802 B1 DK170802 B1 DK 170802B1 DK 434488 A DK434488 A DK 434488A DK 434488 A DK434488 A DK 434488A DK 170802 B1 DK170802 B1 DK 170802B1
Authority
DK
Denmark
Prior art keywords
methyl
endo
azabicyclo
octane
formula
Prior art date
Application number
DK434488A
Other languages
Danish (da)
English (en)
Other versions
DK434488D0 (da
DK434488A (da
Inventor
Ian Anthony Cliffe
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878718444A external-priority patent/GB8718444D0/en
Priority claimed from GB888811975A external-priority patent/GB8811975D0/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of DK434488D0 publication Critical patent/DK434488D0/da
Publication of DK434488A publication Critical patent/DK434488A/da
Application granted granted Critical
Publication of DK170802B1 publication Critical patent/DK170802B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK434488A 1987-08-04 1988-08-03 Azabicycliske ethere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og far maceutiske præparater indeholdende dem DK170802B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878718444A GB8718444D0 (en) 1987-08-04 1987-08-04 Ethers
GB8718444 1987-08-04
GB888811975A GB8811975D0 (en) 1988-05-20 1988-05-20 Ethers
GB8811975 1988-05-20

Publications (3)

Publication Number Publication Date
DK434488D0 DK434488D0 (da) 1988-08-03
DK434488A DK434488A (da) 1989-02-05
DK170802B1 true DK170802B1 (da) 1996-01-22

Family

ID=26292571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434488A DK170802B1 (da) 1987-08-04 1988-08-03 Azabicycliske ethere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og far maceutiske præparater indeholdende dem

Country Status (15)

Country Link
US (3) US4929625A (hu)
EP (1) EP0306148B1 (hu)
JP (1) JP2711272B2 (hu)
KR (1) KR970002635B1 (hu)
AU (1) AU605896B2 (hu)
CA (1) CA1307790C (hu)
DE (1) DE3887039T2 (hu)
DK (1) DK170802B1 (hu)
ES (1) ES2061660T3 (hu)
FI (1) FI94250C (hu)
GB (1) GB2208510B (hu)
HU (1) HU203348B (hu)
IE (1) IE61026B1 (hu)
IL (1) IL87329A (hu)
PT (1) PT88177B (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230881B (it) * 1989-06-20 1991-11-08 Angeli Inst Spa Derivati del r(-) 3-chinuclidinolo
IE65997B1 (en) * 1990-05-11 1995-11-29 Sankyo Co Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives their preparation and their therapeutic use
YU84791A (sh) * 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
GB9019973D0 (en) * 1990-09-12 1990-10-24 Wyeth John & Brother Ltd Azabicyclic derivatives
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
US5948793A (en) * 1992-10-09 1999-09-07 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5512574A (en) * 1994-12-21 1996-04-30 American Home Products Corporation Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
JP2000500452A (ja) * 1995-11-13 2000-01-18 イーライ・リリー・アンド・カンパニー 不安の処置法
US5998434A (en) * 1995-12-06 1999-12-07 Eli Lilly And Company Composition for treating pain
US6133253A (en) * 1996-12-10 2000-10-17 Abbott Laboratories 3-Pyridyl enantiomers and their use as analgesics
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US20030147697A1 (en) * 2002-02-06 2003-08-07 Brady Patrick Richard Evaporative desorption soil treatment apparatus and process
KR20050055711A (ko) * 2002-08-14 2005-06-13 뉴로서치 에이/에스 신규한 퀴누클리딘 유도체 및 이를 포함하는 약제학적 조성물
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
US7418763B2 (en) * 2003-02-26 2008-09-02 Black & Decker Inc. Hand vacuum with filter indicator
WO2004113334A1 (en) * 2003-06-24 2004-12-29 Neurosearch A/S Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
JP5420398B2 (ja) * 2006-05-19 2014-02-19 アッヴィ・バハマズ・リミテッド Ｃｎｓ活性縮合ビシクロ複素環置換アザ二環式アルカン誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2640829A (en) * 1950-11-10 1953-06-02 Smith Kline French Lab Isoquinolyl heterocyclic ethers
NL7109301A (hu) * 1970-07-15 1972-01-18
US4261990A (en) * 1979-03-09 1981-04-14 Ciba-Geigy Corporation N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
GB8302483D0 (en) * 1983-01-29 1983-03-02 Beecham Group Plc Compounds
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
GB8718445D0 (en) * 1987-08-04 1987-09-09 Wyeth John & Brother Ltd Pyridyl-ethers
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
DE3839385A1 (de) * 1988-11-22 1990-05-23 Boehringer Ingelheim Kg Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GB8818323D0 (en) 1988-09-07
DK434488D0 (da) 1988-08-03
IE61026B1 (en) 1994-09-07
PT88177B (pt) 1995-03-01
IE882375L (en) 1989-02-04
CA1307790C (en) 1992-09-22
KR970002635B1 (ko) 1997-03-07
KR890003753A (ko) 1989-04-17
EP0306148A2 (en) 1989-03-08
FI94250B (fi) 1995-04-28
ES2061660T3 (es) 1994-12-16
IL87329A (en) 1992-12-01
GB2208510B (en) 1991-03-06
DK434488A (da) 1989-02-05
AU2035988A (en) 1989-02-09
PT88177A (pt) 1989-06-30
EP0306148A3 (en) 1990-05-23
GB2208510A (en) 1989-04-05
JP2711272B2 (ja) 1998-02-10
DE3887039T2 (de) 1994-04-28
US4997839A (en) 1991-03-05
FI94250C (fi) 1995-08-10
AU605896B2 (en) 1991-01-24
JPH0193585A (ja) 1989-04-12
HUT48247A (en) 1989-05-29
HU203348B (en) 1991-07-29
FI883632A (fi) 1989-02-05
US5082843A (en) 1992-01-21
EP0306148B1 (en) 1994-01-12
FI883632A0 (fi) 1988-08-03
IL87329A0 (en) 1989-01-31
US4929625A (en) 1990-05-29
DE3887039D1 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
DK170802B1 (da) Azabicycliske ethere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og far maceutiske præparater indeholdende dem
Anzini et al. Novel, potent, and selective 5-HT3 receptor antagonists based on the arylpiperazine skeleton: synthesis, structure, biological activity, and comparative molecular field analysis studies
CA1337347C (en) Benzimidazoline-2-one-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
WO1992015593A1 (en) New imidazopyridines as serotonergic 5-ht3 antagonists
EP0361629A2 (en) Heterocyclic compounds
PH12014501417B1 (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
US4873331A (en) Noradamantyl-carboxylic acid piperazinoalkyl esters
IE59680B1 (en) 3,3-Disubstituted Indolines
CA2089770A1 (en) Heterocyclic compounds and their preparation and use
US5391549A (en) Cinnoline-3-carboxylic acid derivatives
US4921860A (en) Quinuclidyl- and tropanyl-pyridyl ethers as 5-HT3 receptor antagonists
JPH01132567A (ja) 新規アミジノ三環誘導体
AU1594988A (en) Psychotropic bicyclic imides
NO322826B1 (no) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyrinderivater, deres fremstilling, sammensetningen omfattende denne og deres anvendelse.
CZ284754B6 (cs) N-(Aryloxyalkyl)heteroaryl-8-azabicyklo/3.2.1/ oktany, meziprodukty a způsob jejich přípavy a jejich použití jako léčiv
US5204470A (en) Azabicyclic derivatives
IL258606A (en) Dopamine d3 receptor antagonists with a morpholine complex
JP2005104896A (ja) ２−アルコキシ−６−アミノ−５−ハロゲノピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物
EP0827500B1 (en) (2-morpholinylmethyl)benzamide derivatives
US4003904A (en) Anti-diarrheal oxadiazoles
US4906642A (en) Pyridine derivatives
Cliffe et al. Quinuclidyl-and tropanyl-pyridyl ethers as 5-HT 3 receptor antagonists
EP2065386A1 (de) CGRP Antagonisten
JP2008504332A (ja) ドーパミンｄ３受容体に対してアフィニティーを有する化合物およびその医薬における使用
JPS5890569A (ja) テトラゾ−ル誘導体およびその製造法

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK